首页> 外文期刊>World Journal of Surgical Oncology >Prognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breast
【24h】

Prognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breast

机译:TMEM16A,PPFIA1和FADD表达在乳腺浸润性导管癌中的预后意义

获取原文
           

摘要

Background 11q13 region is a frequently amplified locus in human malignancies. Among the genes located in this region, FADD is one of the alleged driving genes. Because amplification is not generally confined to a single gene and amplified genes may not show increased expression, we need to evaluate clinical significance of changes occurring in 11q13 region to understand their roles in carcinogenesis. Therefore, we screened expressions of FADD and closely located genes ( PPFIA1 and TMEM16A ) and evaluated the expressions to find clinical significance in invasive ductal carcinoma of the breast. Methods Ninety-eight cases of invasive ductal carcinoma of the breast were collected. Using archival tissues resected from the cases, we built a tissue microarray and used it in immunohistochemistry. We evaluated the association of FADD , PPFIA1 , and TMEM16A expression scores with clinicopathological parameters, including disease-free survival. Results FADD expression was associated with T stage ( P =?0.046). The combined score of FADD , PPFIA1 , and TMEM16A gene expressions was associated with perineural invasion ( P =?0.022). Although individual gene expressions of TMEM16A, FADD, and PPFIA1 failed to show significant association with disease-free survival, combined gene expression scores did show association with disease-free survival ( P =?0.034). Conclusions FADD , TMEM16A , and PPFIA1 gene expressions as a whole were associated with disease-free survival in breast cancer.
机译:背景11q13区是人类恶性肿瘤中经常扩增的基因座。在位于该区域的基因中,FADD是所谓的驱动基因之一。由于扩增通常不限于单个基因,并且扩增的基因可能未显示出增加的表达,因此我们需要评估11q13区发生的变化的临床意义,以了解其在癌变中的作用。因此,我们筛选了FADD和紧密定位的基因(PPFIA1和TMEM16A)的表达,并对表达进行了评估,以发现其在乳腺浸润性导管癌中的临床意义。方法收集98例乳腺浸润性导管癌病例。使用从病例中切除的档案组织,我们建立了组织微阵列并将其用于免疫组织化学。我们评估了FADD,PPFIA1和TMEM16A表达评分与临床病理参数(包括无病生存期)的关系。结果FADD表达与T期有关(P =?0.046)。 FADD,PPFIA1和TMEM16A基因表达的总分与神经周浸润有关(P =?0.022)。尽管TMEM16A,FADD和PPFIA1的单个基因表达未能显示出与无病生存的显着相关性,但综合基因表达评分确实显示出与无病生存的相关性(P =?0.034)。结论FADD,TMEM16A和PPFIA1基因的整体表达与乳腺癌的无病生存有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号